Expansion of the Medicare drug price negotiation rare disease drug carve-out would unnecessarily limit the number of drugs ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

President Trump's order calls for correcting this imbalance. The Republican-backed EPIC Act offers the clearest solution, ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Senate Republicans released their version of the Trump administration’s “One Big Beautiful Bill Act” on Monday with a few ...

The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...

Making prescription drugs more affordable was a key goal of the Inflation Reduction Act (IRA). However, most Medicare ...

Medicare "Part E" would be self-sustaining, funded by premiums, and available through all state and federal health exchanges.

Americans pay disproportionately to subsidize pharmaceutical innovation, while the rest of the world benefits and pays less ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...